Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aspirin
Thornton & Ross Ltd
B01AC06
Aspirin
75mg
Dispersible tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02090000
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dispersible Aspirin Tablets BP 75mg Dispersible Aspirin 75mg Tablets POST MI® 75mg Dispersible Tablets Boots Aspirin 75mg Dispersible tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aspirin BP 75.0mg 3. PHARMACEUTICAL FORM Dispersible tablets 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75-150mg daily. In some circumstances, a higher dose may be appropriate, especially in the short term, and up to 300mg a day may be used on the advice of a doctor. _Children: _Do not give to children aged under 16 years, unless specifically indicated (e.g. for Kawasaki’s disease). 4.3 CONTRAINDICATIONS Aspirin is contraindicated in patients with; • active peptic ulceration or a history of peptic ulceration. • Haemophilia, haemorrhagic disease or a history of bleeding disorders. • Gout or a history of gout. • Hypersensitivity to aspirin (e.g. asthma, rhinitis, angioedema or urticaria), other NSAIDs or other tablet excipients • During the third trimester of pregnancy • children under 16 (except for the treatment of Still’s disease), • breast feeding,. • concurrent anticoagulant therapy. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Before commencing long term aspirin therapy, for the management of cardiovascular and cerebrovascular disease, patients should consult their doctor who can advise on the relative benefits versus the risks for the individual patient. Administer with caution in the presence of renal or hepatic impairment, dehydration. There is a possible association between aspirin and Reye’s syndrome when given to children. Reye’s syndrome is a very rare disease, which affects the brain and liver and can be fatal. For this reason aspirin should n Read the complete document